01
Approved treatment options
A diagnosis-specific summary of standard-of-care therapies, aligned to current oncology guidance for the patient's cancer type.
Patient-first oncology intelligence
At cancer diagnosis, patients deserve the data behind every treatment option.
TrialTriage gives newly diagnosed cancer patients and their oncologists a patient-friendly report with approved treatment options, FDA efficacy data, and matched clinical trials — so better decisions can happen before treatment begins.
Sample patient report
At a glance
8+
24–48hrs
50mi
Why this matters for payers
Oncology cost pressure is a plan-level conversation now.
TrialTriage helps plans surface trial options earlier, document referral flow, and create a more credible oncology savings conversation.
$196K
Median annual oncology drug cost
Specialty treatment pressure compounds before downstream utilization is counted. JAMA Internal Medicine
Oncology vs. overall pharmacy spend growth
Oncology pharmacy growing 3.7× faster than overall pharmacy — a leading renewal pressure driver.
Raised too late
When trial options typically surface
In routine care, trial discussions often begin after first-line decisions are already underway.
60–70%
Cost offset potential at enrollment
Eligible trial enrollment may shift a meaningful share of treatment cost to sponsor-funded care.
What the report gives
One report. Built for real treatment decisions.
Patients and oncologists can review standard treatment options, supporting evidence, and nearby clinical trials — in one place, before first-line therapy begins.
See a Sample Report →02
FDA efficacy data
Why it matters: Without knowing how effective existing standard-of-care drugs are for their specific diagnosis, patients have no informed basis to evaluate whether a clinical trial is worth considering.
The report translates that treatment effectiveness evidence into plain language — so the trial conversation starts from a clear, documented baseline, not assumptions.
03
Matched clinical trials nearby
Open trial options surfaced with trial site names, addresses, and distance from the patient's home ZIP — practical access, not a database search.
How it works
Simple workflow. Qualified handoff.
TrialTriage is designed to fit existing advocacy and care-navigation programs — and only moves forward with trial sites once a patient has expressed interest.
1
Diagnosis identified
A new cancer diagnosis is flagged through claims, care management, or patient self-referral.
2
Report delivered
A personalized report goes to the patient and oncology care team — approved options, evidence, and matched trials — before the first visit where possible.
3
Concierge review
TrialTriage Concierge answers questions, helps the patient understand the report, and completes a pre-screen for matched trials.
4
Trial-site handoff
If the patient is interested, TrialTriage coordinates the handoff to the trial site's research team. Only qualified, consenting patients move forward.
Who it helps
Built for the people making oncology decisions.
Payers
Earlier visibility into cost-offset pathways
Surface sponsor-funded trial opportunities before first-line decisions are locked in.
Providers
Informed conversations without extra work
The care team receives the report before the patient visit — no manual data assembly required.
Patients
Options and evidence before day one of treatment
A plain-language report so newly diagnosed patients can ask better questions and make more confident decisions.
Pharma
A more structured patient referral path
Reach interested, geographically relevant patients earlier through a qualified concierge workflow.